Fidelity SPDR Advertisement
Home > Boards > Free Zone > User's Groups > Smack Down Penny Stocks!

CPVD

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Mick Dodge Member Profile
Member Level 
Followed By 579
Posts 57,133
Boards Moderated 4
Alias Born 03/02/10
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Repsol to Buy Talisman Energy for $8.3 Billion --Update
How a Memo Cost Big Banks $37 Billion
Mobile's Rise Poses a Riddle for Banks
Nike Sees Jump in Sales, Growth Concerns -- 4th Update
Sprint to Face Record Fine Over Unauthorized Customer Charges
ADR Shares End Lower; BT Group Shares Trade Actively
Oracle Beats Street View for First Time in a Year
Mick Dodge Member Level  Sunday, 03/04/12 12:06:01 PM
Re: None
Post # of 864 
CPVD
Security Notes
New Issue=11-85 30,000,000 shs in units (1 sh Com, 1 Class A Warr 11-27-86 & 1 Class B Warr 11-27-87) at 3 cents per unit (best efforts-all or none) by Royce Park Investments, Inc.

IF YOU LIKE THE CHARTS HIT ME UP WITH A PERSON MARK
http://investorshub.advfn.com/boards/profilea.aspx?user=192141
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist